Tapewire

Nasdaq · USD

DNLI

Denali Therapeutics Inc.

Export transactions ↓
Tapewire entity
1735
SEC CIK
0001714899
Parsed reports
436

Last 12 months

Inside the activity.

0 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202602
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 07, 2017 Filed Dec 8, 2017 22:58 UTC
SATO VICKI LDirector
GrantStock Option (right to buy) · Derivative 47,165 $0.00 Strike: $18.00 $0.00
Disclosure

SEC source: 0001209191-17-064809 · doc4.xml · derivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,165

Underlying: Common Stock · 47,165 shares

Expires 2027-12-06

F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on December 7, 2018 and an additional 1/48 of the shares vest monthly thereafter.

Read SEC document
December 07, 2017 Filed Dec 8, 2017 22:57 UTC
NELSEN ROBERTDirector · 10% owner
GrantStock Option (right to buy) · Derivative 47,165 $0.00 Strike: $18.00 $0.00
Disclosure

SEC source: 0001209191-17-064808 · doc4.xml · derivative · entry 1

NELSEN ROBERT · CIK 0001219042 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,165

Underlying: Common Stock · 47,165 shares

Expires 2027-12-06

F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on December 7, 2018 and an additional 1/48 of the shares vest monthly thereafter.

Read SEC document
December 07, 2017 Filed Dec 8, 2017 22:54 UTC GrantStock Option (right to buy) · Derivative 47,165 $0.00 Strike: $18.00 $0.00
Disclosure

SEC source: 0001209191-17-064804 · doc4.xml · derivative · entry 1

Cole Douglas G. · CIK 0001486373 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,165

Underlying: Common Stock · 47,165 shares

Expires 2027-12-06

F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on December 7, 2018 and an additional 1/48 of the shares vest monthly thereafter.

Read SEC document
December 07, 2017 Filed Dec 8, 2017 22:55 UTC GrantStock Option (right to buy) · Derivative 47,165 $0.00 Strike: $18.00 $0.00
Disclosure

SEC source: 0001209191-17-064805 · doc4.xml · derivative · entry 1

FLATLEY JAY T · CIK 0001189130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,165

Underlying: Common Stock · 47,165 shares

Expires 2027-12-06

F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on December 7, 2018 and an additional 1/48 of the shares vest monthly thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.